Tomoyuki Aruga

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Chemotherapy Induced

Epidermal Growth Factor Receptor

Placebo Controlled

Top Venues

Breast cancer research and treatment

Diagnostics (Basel, Switzerland)

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mio Adachi, Toshiyuki Ishiba, Sakiko Maruya, Kumiko Hayashi, Yuichi Kumaki, Goshi Oda, Tomoyuki Aruga
Relationship between Volpara Density Grade and Compressed Breast Thickness in Japanese Patients with Breast Cancer. Diagnostics (Basel, Switzerland) 14 (15) (2024)
Toshimi Takano, Norikazu Masuda, Mitsuya Ito, Kenichi Inoue, Yuko Tanabe, Kousuke Kawaguchi, Hiroyuki Yasojima, Hiroko Bando, Rikiya Nakamura, Takashi Yamanaka, Kazushige Ishida, Tomoyuki Aruga, Yasuhiro Yanagita, Eriko Tokunaga, Kenjiro Aogi, Shinji Ohno, Hiroi Kasai, Tatsuki R Kataoka, Satoshi Morita, Masakazu Toi
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks). Breast cancer research and treatment 207 (1) (2024)
Toshimi Takano, Norikazu Masuda, Mitsuya Ito, Kenichi Inoue, Yuko Tanabe, Kousuke Kawaguchi, Hiroyuki Yasojima, Hiroko Bando, Rikiya Nakamura, Takashi Yamanaka, Kazushige Ishida, Tomoyuki Aruga, Yasuhiro Yanagita, Eriko Tokunaga, Kenjiro Aogi, Shinji Ohno, Hiroi Kasai, Tatsuki R Kataoka, Satoshi Morita, Masakazu Toi
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks). Breast cancer research and treatment (2024)
Toshimi Takano, Norikazu Masuda, Mitsuya Ito, Kenichi Inoue, Yuko Tanabe, Kousuke Kawaguchi, Hiroyuki Yasojima, Hiroko Bando, Rikiya Nakamura, Takashi Yamanaka, Kazushige Ishida, Tomoyuki Aruga, Yasuhiro Yanagita, Eriko Tokunaga, Kenjiro Aogi, Shinji Ohno, Hiroi Kasai, Tatsuki R Kataoka, Satoshi Morita, Masakazu Toi
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks). Breast cancer research and treatment 207 (1) (2024)
Mio Adachi, Toshiyuki Ishiba, Sakiko Maruya, Kumiko Hayashi, Yuichi Kumaki, Goshi Oda, Tomoyuki Aruga
Relationship between Volpara Density Grade and Compressed Breast Thickness in Japanese Patients with Breast Cancer. Diagnostics (Basel, Switzerland) 14 (15) (2024)
Toshimi Takano, Norikazu Masuda, Mitsuya Ito, Kenichi Inoue, Yuko Tanabe, Kousuke Kawaguchi, Hiroyuki Yasojima, Hiroko Bando, Rikiya Nakamura, Takashi Yamanaka, Kazushige Ishida, Tomoyuki Aruga, Yasuhiro Yanagita, Eriko Tokunaga, Kenjiro Aogi, Shinji Ohno, Hiroi Kasai, Tatsuki R Kataoka, Satoshi Morita, Masakazu Toi
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks). Breast cancer research and treatment 207 (1) (2024)
Toshimi Takano, Norikazu Masuda, Mitsuya Ito, Kenichi Inoue, Yuko Tanabe, Kousuke Kawaguchi, Hiroyuki Yasojima, Hiroko Bando, Rikiya Nakamura, Takashi Yamanaka, Kazushige Ishida, Tomoyuki Aruga, Yasuhiro Yanagita, Eriko Tokunaga, Kenjiro Aogi, Shinji Ohno, Hiroi Kasai, Tatsuki R Kataoka, Satoshi Morita, Masakazu Toi
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks). Breast cancer research and treatment 207 (1) (2024)
Toshimi Takano, Mitsuya Ito, Takayuki Kadoya, Tomofumi Osako, Tomoyuki Aruga, Norikazu Masuda, Toshiko Miyaki, Naoki Niikura, Daisuke Shimizu, Yuichi Yokoyama, Manabu Watanabe, Masato Tomomitsu, Kenjiro Aogi
Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III. Cancer medicine (2023)
Tomoyuki Aruga, Hiroyoshi Doihara, Yasuhiro Yanagita, Takanori Ishida, Toshinari Yamashita, Kanou Uehara, Tetsuhiko Taira, Junji Tsurutani, Takashi Takeshita, Shigeru Tsuyuki, Koji Kaneko, Tohru Ohtake, Yusuke Yamaguchi, Yui Hara, Shigehira Saji
Evaluation of a novel medical device for pegfilgrastim administration. Cancer science 113 (5) (2022)
Miyako Nara, Sakiko Ishihara, Atsuko Kitano, Nobuko Tamura, Tomoyuki Aruga, Daiki Kobayashi, Seigo Nakamura, Hideko Yamauchi
Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis. Breast cancer (Tokyo, Japan) 29 (3) (2022)